362 related articles for article (PubMed ID: 24656035)
1. Shared molecular eplet stimulates acute antibody-mediated rejection in a kidney transplant recipient with low-level donor-specific antibodies: a case report.
Mongkolsuk T; Ingsathit A; Worawichawong S; Jirasiritham S; Kitpoka P; Thammanichanond D
Transplant Proc; 2014; 46(2):644-7. PubMed ID: 24656035
[TBL] [Abstract][Full Text] [Related]
2. HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization.
Bosch A; Llorente S; Eguia J; Mrowiec A; Boix F; López-Hernández R; Campillo JA; Salgado G; Moya-Quiles MR; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Hum Immunol; 2014 Apr; 75(4):338-41. PubMed ID: 24486575
[TBL] [Abstract][Full Text] [Related]
3. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
[TBL] [Abstract][Full Text] [Related]
4. Repeated human leukocyte antigens eplets, importance of typing the partner.
Dos Reis Ferreira C; da Silva Fernandes VM; Tafulo SCR; Cerqueira A; Rocha ACB; Nunes ATPM; Ferreira IPCN; Santos MJC; Pinho ATMT; Tavares IC; Guerra MMBB; Norton SMMS
Transpl Immunol; 2024 Jun; 84():102049. PubMed ID: 38729449
[TBL] [Abstract][Full Text] [Related]
5. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
6. Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report.
Thammanichanond D; Parapiboon W; Mongkolsuk T; Worawichawong S; Tammakorn C; Kitpoka P
Transplant Proc; 2018 Oct; 50(8):2548-2552. PubMed ID: 30316396
[TBL] [Abstract][Full Text] [Related]
7. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report.
Thammanichanond D; Tammakorn C; Worawichawong S; Kantachuvesiri S
Transplant Proc; 2020; 52(6):1931-1936. PubMed ID: 32444122
[TBL] [Abstract][Full Text] [Related]
9. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
10. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
[TBL] [Abstract][Full Text] [Related]
11. Antibody-mediated rejection owing to donor-specific HLA-DQA1 antibodies after renal transplantation: A case report.
Liu W; Kang ZY; Wang ZL; Li DH
Transpl Immunol; 2022 Aug; 73():101607. PubMed ID: 35477043
[TBL] [Abstract][Full Text] [Related]
12. HLA Epitopes and Shared Molecular Eplet Characterization and Their Implication on Transplant Outcome: The Experience of One Center.
Bosch A; Eguia J; Boix F; López M; González-Martinez G; Galian JA; Moya-Quiles MR; Llorente S; Muro M
Clin Transpl; 2016; 32():73-82. PubMed ID: 28564524
[TBL] [Abstract][Full Text] [Related]
13. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
16. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
[TBL] [Abstract][Full Text] [Related]
17. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
[TBL] [Abstract][Full Text] [Related]
18. Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation.
Chauhan R; Tiwari AK; Aggarwal G; Gowri Suresh L; Kumar M; Bansal SB
Transpl Immunol; 2023 Dec; 81():101931. PubMed ID: 37730185
[TBL] [Abstract][Full Text] [Related]
19. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
Fidler S; Swaminathan R; Lim W; Ferrari P; Witt C; Christiansen FT; D'Orsogna LJ; Irish AB
Transpl Immunol; 2013 Dec; 29(1-4):22-7. PubMed ID: 24090807
[TBL] [Abstract][Full Text] [Related]
20. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
Yell M; Muth BL; Kaufman DB; Djamali A; Ellis TM
Transplantation; 2015 Jun; 99(6):1151-5. PubMed ID: 25839705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]